These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26637806)

  • 1. Molecular heterogeneity of glioblastomas: does location matter?
    Denicolaï E; Tabouret E; Colin C; Metellus P; Nanni I; Boucard C; Tchoghandjian A; Meyronet D; Baeza-Kallee N; Chinot O; Figarella-Branger D
    Oncotarget; 2016 Jan; 7(1):902-13. PubMed ID: 26637806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
    Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
    J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes.
    Orzan F; Pagani F; Cominelli M; Triggiani L; Calza S; De Bacco F; Medicina D; Balzarini P; Panciani PP; Liserre R; Buglione M; Fontanella MM; Medico E; Galli R; Isella C; Boccaccio C; Poliani PL;
    Lab Invest; 2020 Oct; 100(10):1330-1344. PubMed ID: 32404931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
    Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical Markers.
    Nagy Á; Garzuly F; Padányi G; Szűcs I; Feldmann Á; Murnyák B; Hortobágyi T; Kálmán B
    Pathol Oncol Res; 2019 Jan; 25(1):21-31. PubMed ID: 28948518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
    Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
    Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
    Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
    World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.
    Steed TC; Treiber JM; Taha B; Engin HB; Carter H; Patel KS; Dale AM; Carter BS; Chen CC
    J Neurooncol; 2020 Jul; 148(3):455-462. PubMed ID: 32556864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
    Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
    Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.
    Held-Feindt J; Paredes EB; Blömer U; Seidenbecher C; Stark AM; Mehdorn HM; Mentlein R
    Int J Cancer; 2006 Jan; 118(1):55-61. PubMed ID: 16003758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
    Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
    Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
    Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
    Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probabilistic radiographic atlas of glioblastoma phenotypes.
    Ellingson BM; Lai A; Harris RJ; Selfridge JM; Yong WH; Das K; Pope WB; Nghiemphu PL; Vinters HV; Liau LM; Mischel PS; Cloughesy TF
    AJNR Am J Neuroradiol; 2013 Mar; 34(3):533-40. PubMed ID: 22997168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].
    Dmitrenko VV; Ershov AV; Stetsiuk PI; Likhovid AP; Laptin IuP; Shvarts DR; Mekler AA; Kavsan VM
    Tsitol Genet; 2014; 48(6):45-55. PubMed ID: 25536822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
    Carrato C; Alameda F; Esteve-Codina A; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Lopez-Martos R; Barco SD; Ribalta T; Capellades J; Puig J; Gallego O; Mesia C; Muñoz-Marmol AM; Archilla I; Arumí M; Blanc JM; Bellosillo B; Menendez S; Esteve A; Bagué S; Hernandez A; Craven-Bartle J; Fuentes R; Vidal N; Aldecoa I; Iglesia N; Balana C
    Clin Cancer Res; 2020 Dec; 26(24):6600-6609. PubMed ID: 32998960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR.
    Scrideli CA; Carlotti CG; Okamoto OK; Andrade VS; Cortez MA; Motta FJ; Lucio-Eterovic AK; Neder L; Rosemberg S; Oba-Shinjo SM; Marie SK; Tone LG
    J Neurooncol; 2008 Jul; 88(3):281-91. PubMed ID: 18398573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
    Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.